Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04262375 |
Title | A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION (DOMINATION) |
Acronym | DOMINATION |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | University Health Network, Toronto |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2M9 | Canada | Details |